As a class, GLP-1 RAs are extremely effective at treating hyperglycaemia and lowering HbA1c levels in people with T2DM compared to other, well-established therapies, with HbA1c level reductions in the range of 0.5–1.5% compared to placebo [51]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.